Everest Medicines Limited (HKG:1952)
Hong Kong
· Delayed Price · Currency is HKD 35.34
-0.32 (-0.90%)
Apr 29, 2026, 4:08 PM HKT
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of 12.42 billion as of April 29, 2026. Its market cap has decreased by -32.64% in one year.
Market Cap
12.42B
Enterprise Value
10.41B
Revenue
1.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
35.34
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 20.64B to 12.42B, a decrease of -39.84%. That is a compound annual growth rate of -8.74%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CARsgen Therapeutics Holdings | 13.02B |
| HBM Holdings | 11.52B |
| Alphamab Oncology | 10.83B |
| Lepu Biopharma | 10.05B |
| CStone Pharmaceuticals | 15.76B |
| Abbisko Cayman | 9.43B |
| Shanghai Haohai Biological Technology | 9.40B |
| Nanjing Leads Biolabs | 16.80B |